Alivus Life Sciences Ltd. (GLS)
Market Closed
19 Oct, 10:00 AM
XNSE MSE Primary XNSE ₹
1,268. 60
-40.9
-3.1233%
₹
- Market Cap
- P/E Ratio
- Div Yield
136,164 Volume
- Eps
₹ 1,309.5
Previous Close Want to track GLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Alivus Life Sciences Ltd. (GLS) Statistics
Valuation metrics
Market Cap -
Enterprise value 130.23B
Trailing P/E (ttm) 28.26
Forward P/E -
PEG ratio -1.89
Price/Sales (ttm) 5.83
Price/Book (mrq) 5.71
Enterprise Value/Revenue 5.7
Enterprise Value/EBITDA 18.98
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 72.89K
Average volume (90 days) 145.07K
Price summary
52-Week low 819
52-Week high 1,493.8
Beta -
50-Day moving average 1,373.92
200-Day moving average 1,192.97
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.21%
Operating margin 0.39%
Operational effectiveness
Return on assets 0.17%
Return on equity 0.21%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 186.34
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 38.43
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 24.6
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.37%
Book value per share (mrq) 190.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
